Excimer laser coronary atherectomy for uncrossable coronary lesions. A multicenter registry.


Journal

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139

Informations de publication

Date de publication:
01 12 2021
Historique:
revised: 27 10 2020
received: 07 08 2020
accepted: 08 11 2020
pubmed: 25 11 2020
medline: 6 1 2022
entrez: 24 11 2020
Statut: ppublish

Résumé

To assess the efficacy and safety of excimer laser coronary atherectomy (ELCA), as well as, the long-term outcomes and the factors associated with ELCA failure in uncrossable lesions. Uncrossable lesions constitute a challenge for percutaneous coronary intervention. This multicenter registry included 126 patients with 126 uncrossable lesions. Study endpoints were ELCA success, technical success and a composite of cardiac death, myocardial infarction (MI), and target-lesion revascularization (TLR) on follow-up. Predictors of ELCA failure were analyzed. Moderate or severe calcification was present in 79 (62.7%) of the lesions and 58 (46%) were a chronic total occlusion. ELCA success was obtained in 103 (81.8%) patients. Rotational atherectomy was attempted as bailout in 21 out of 23 ELCA failure (91.3%), being successful in 14 (66.7%) of them. Finally, technical and procedural success were achieved in 114 (90.5%) and 110 (87.3%) of the patients. Severe calcification was independently associated with ELCA failure (OR: 3.73, 95% CI: 1.35-10.32; p = .011). Two (1.6%) patients died (one after a stroke and another patient because of heart failure), 4 (3.2%) developed a non-Q MI without clinical consequences and 1 (0.8%) patient had a Q-MI. Other complications were ventricular tachycardia/fibrillation (n = 2; 1.6%) and flow-limiting dissection (n = 1, 0.8%). At follow-up (median 424 days), 3 (2.4%) patients died (1 (0.8%) from cardiovascular cause) and 15 (11.9%) required TLR. In our multicenter experience, ELCA use demonstrated to be safe and reasonably effective with a rate of events on follow-up relatively low. Severe calcification was associated with ELCA failure.

Sections du résumé

OBJECTIVES
To assess the efficacy and safety of excimer laser coronary atherectomy (ELCA), as well as, the long-term outcomes and the factors associated with ELCA failure in uncrossable lesions.
BACKGROUND
Uncrossable lesions constitute a challenge for percutaneous coronary intervention.
METHODS
This multicenter registry included 126 patients with 126 uncrossable lesions. Study endpoints were ELCA success, technical success and a composite of cardiac death, myocardial infarction (MI), and target-lesion revascularization (TLR) on follow-up. Predictors of ELCA failure were analyzed.
RESULTS
Moderate or severe calcification was present in 79 (62.7%) of the lesions and 58 (46%) were a chronic total occlusion. ELCA success was obtained in 103 (81.8%) patients. Rotational atherectomy was attempted as bailout in 21 out of 23 ELCA failure (91.3%), being successful in 14 (66.7%) of them. Finally, technical and procedural success were achieved in 114 (90.5%) and 110 (87.3%) of the patients. Severe calcification was independently associated with ELCA failure (OR: 3.73, 95% CI: 1.35-10.32; p = .011). Two (1.6%) patients died (one after a stroke and another patient because of heart failure), 4 (3.2%) developed a non-Q MI without clinical consequences and 1 (0.8%) patient had a Q-MI. Other complications were ventricular tachycardia/fibrillation (n = 2; 1.6%) and flow-limiting dissection (n = 1, 0.8%). At follow-up (median 424 days), 3 (2.4%) patients died (1 (0.8%) from cardiovascular cause) and 15 (11.9%) required TLR.
CONCLUSIONS
In our multicenter experience, ELCA use demonstrated to be safe and reasonably effective with a rate of events on follow-up relatively low. Severe calcification was associated with ELCA failure.

Identifiants

pubmed: 33232583
doi: 10.1002/ccd.29392
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1241-1249

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

Rathore S, Matsuo H, Terashima M, et al. Rotational atherectomy for fibro-calcific coronary artery disease in drug eluting stent era: procedural outcomes and angiographic follow-up results. Catheter Cardiovasc Interv. 2010;75:919-927.
Couper LT, Loane P, Andrianopoulos N, et al. Melbourne interventional group (MIG) investigators. Utility of rotational atherectomy and outcomes over an eight-year period. Catheter Cardiovasc Interv. 2015;86:626-631.
Shavadia JS, Vo MN, Bainey KR. Challenges with severe coronary artery calcification in percutaneous coronary intervention: a narrative review of therapeutic options. Can J Cardiol. 2018;34:1564-1572.
De Maria GL, Scarsini R, Banning AP. Management of calcific coronary artery lesions. Is it time to change our interventional therapeutic approach? JACC Cardiovasc Interv. 2019;12:1465-1478.
Tajti P, Karmpaliotis D, Alaswad K, et al. Prevalence, presentation and treatment of 'Balloon Undilatable' chronic total occlusions: insights from a multicenter US registry. Catheter Cardiovasc Interv. 2018;91:657-666.
Egred M, Brilakis ES. Excimer laser coronary angioplasty (ELCA): fundamentals, mechanism of action, and clinical applications. J Invasive Cardiol. 2020;32:E27-E35.
Deckelbaum LI, Natarajan MK, Bittl JA, et al. Effect of intracoronary saline infusion on dissection during excimer laser coronary angioplasty: a randomized trial. The percutaneous excimer laser coronary angioplasty (PELCA) investigators. J Am Coll Cardiol. 1995;26:1264-1269.
Ellis SG, Ajluni S, Arnold AZ, et al. Increased coronary perforation in the new device era. Incidence, classification, management, and outcome. Circulation. 1994;90:2725-2730.
Thygesen K, Alpert JS, Jaffe AS, et al. ESC scientific document group, fourth universal definition of myocardial infarction. Eur Heart J. 2019;40:237-269.
Appelman YE, Piek JJ, Strikwerda S, et al. Randomized trial of excimer laser versus balloon angioplasty for treatment of obstructive coronary artery disease. Lancet. 1996;347:79-84.
Fretz EB, Smith P, Hilton D. Initial experience with a low profile, high energy excimer laser catheter for heavily calcified coronary lesion debulking: parameters and results of first seven human case experiences. J Interv Cardiol. 2001;14:433-437.
Rawlins J, Din JN, Talwar S, O'Kane P. Coronary intervention with the excimer laser: review of the technology and outcome data. Interv Cardiol. 2016;11:27-32.
Sueta D, Hokimoto S, Miyazaki T, et al. Usefulness of excimer laser atherectomy for balloon uncrossable lesion in chronic total occlusion. Int J Cardiol Heart Vasc. 2015;9:70-72.
Fernandez JP, Hobson AR, McKenzie D, et al. Beyond the balloon: excimer coronary laser atherectomy used alone or in combination with rotational atherectomy in the treatment of chronic total occlusions, non-crossable and non-expansible coronary lesions. EuroIntervention. 2013;9:243-250.
Azzalini L, Ly HQ. Laser atherectomy for balloon failure in chronic total occlusion. When the going gets tough. Int Heart J. 2014;55:546-549.
Karacsonyi J, Karmpaliotis D, Alaswad K, et al. Prevalence, indications and management of balloon uncrossable chronic total occlusions: insights from a contemporary multicenter US registry. Cath Catheter Cardiovasc Interv. 2017;90:12-20.
Elrayes MM, Xenogiannis I, Nikolakopoulos I, et al. An algorithmic approach to balloon-uncrossable coronary lesions. Catheter Cardiovasc Interv. 2020. https://doi.org/10.1002/ccd.29215. [Epub ahead of print].
Karacsonyi J, Armstrong EJ, Truong HTD, et al. Contemporary use of laser during percutaneous coronary interventions: insights from the laser veterans affairs (LAVA) multicenter registry. J Invasive Cardiol. 2018;30:195-201.
Bilodeau L, Fretz EB, Taeymans Y, Koolen J, Taylor K, Hilton DJ. Novel use of a high energy excimer laser catheter for calcified and complex coronary artery lesions. Catheter Cardiovasc Interv. 2004;62:155-161.
Bittl JA, Brinker JA, Isner JM, Sanborn TA, Tcheng JE. The changing profile of patient selection, techniques, and outcomes in excimer laser angioplasty. J Interv Cardiol. 1995;8:653-660.
Litvack F, Eigler N, Margolis J, et al. Percutaneous excimer laser coronary angioplasty: results in the first consecutive 3000 patients. J Am Coll Cardiol. 1994;23:323-330.

Auteurs

Soledad Ojeda (S)

Division of Interventional Cardiology, Reina Sofia Hospital, University of Córdoba, Maimonides Institute for Research in Biomedicine of Córdoba (IMIBIC), Córdoba, Spain.

Lorenzo Azzalini (L)

Division of Cardiology, VCU Health Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia, USA.
The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Javier Suárez de Lezo (J)

Division of Interventional Cardiology, Reina Sofia Hospital, University of Córdoba, Maimonides Institute for Research in Biomedicine of Córdoba (IMIBIC), Córdoba, Spain.

Gurpreet S Johal (GS)

The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Rafael González (R)

Division of Interventional Cardiology, Reina Sofia Hospital, University of Córdoba, Maimonides Institute for Research in Biomedicine of Córdoba (IMIBIC), Córdoba, Spain.

Nitin Barman (N)

The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Francisco Hidalgo (F)

Division of Interventional Cardiology, Reina Sofia Hospital, University of Córdoba, Maimonides Institute for Research in Biomedicine of Córdoba (IMIBIC), Córdoba, Spain.

Neus Bellera (N)

Division of Interventional Cardiology, Hospital Universitario Vall d'Hebron, Centro de Investigación Biomédica en Red, CIBER CV, Barcelona, Spain.

George Dangas (G)

The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Alfonso Jurado-Román (A)

Division of Interventional Cardiology, Hospital La Paz, IDIPAZ, CIBER-CV, Madrid, Spain.

Annapoorna Kini (A)

The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Miguel Romero (M)

Division of Interventional Cardiology, Reina Sofia Hospital, University of Córdoba, Maimonides Institute for Research in Biomedicine of Córdoba (IMIBIC), Córdoba, Spain.

Raúl Moreno (R)

Division of Interventional Cardiology, Hospital La Paz, IDIPAZ, CIBER-CV, Madrid, Spain.

Bruno Garcia Del Blanco (B)

Division of Interventional Cardiology, Hospital Universitario Vall d'Hebron, Centro de Investigación Biomédica en Red, CIBER CV, Barcelona, Spain.

Roxana Mehran (R)

The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Samin K Sharma (SK)

The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Manuel Pan (M)

Division of Interventional Cardiology, Reina Sofia Hospital, University of Córdoba, Maimonides Institute for Research in Biomedicine of Córdoba (IMIBIC), Córdoba, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH